Variant report
Variant | esv3328225 |
---|---|
Chromosome Location | chr6:46005893-46010391 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:1)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr6:46002982..46005578-chr6:46009037..46013212,3 | MCF-7 | breast: |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs539238796 | chr6:46005927-46005928 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs368115493 | chr6:46005940-46005941 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs557940358 | chr6:46005948-46005949 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs187249632 | chr6:46005998-46005999 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs531440896 | chr6:46006032-46006033 | Active TSS Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs537170901 | chr6:46006043-46006044 | Active TSS Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs555028920 | chr6:46006086-46006087 | Active TSS Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs573664303 | chr6:46006097-46006098 | Active TSS Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs192869368 | chr6:46006177-46006178 | Active TSS Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs553701052 | chr6:46006216-46006217 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs578260633 | chr6:46006249-46006250 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs545233228 | chr6:46006265-46006266 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs563912606 | chr6:46006324-46006325 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs373613127 | chr6:46006339-46006340 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs543089704 | chr6:46006386-46006387 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs138912685 | chr6:46006405-46006406 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs62400490 | chr6:46006472-46006473 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
18 | rs546629368 | chr6:46006525-46006526 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs79278307 | chr6:46006537-46006538 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs143738230 | chr6:46006558-46006559 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs185787185 | chr6:46006590-46006591 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs551257798 | chr6:46006595-46006596 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs569849201 | chr6:46006618-46006619 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs536883590 | chr6:46006688-46006689 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs555420193 | chr6:46006698-46006699 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs74946614 | chr6:46006743-46006744 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs377680812 | chr6:46006793-46006794 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs534593270 | chr6:46006838-46006839 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs553015797 | chr6:46006854-46006855 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs578238895 | chr6:46006905-46006906 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs545708131 | chr6:46006919-46006920 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs557400856 | chr6:46006939-46006940 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs79401000 | chr6:46006950-46006951 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs542897884 | chr6:46006953-46006954 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs561035928 | chr6:46007089-46007090 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs115617951 | chr6:46007097-46007098 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs540187620 | chr6:46007124-46007125 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs35899190 | chr6:46007128-46007129 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs78472015 | chr6:46007135-46007136 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs559195405 | chr6:46007168-46007169 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs571841851 | chr6:46007195-46007196 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs534142504 | chr6:46007202-46007203 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs190363499 | chr6:46007212-46007213 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs569880344 | chr6:46007222-46007223 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs530731578 | chr6:46007230-46007231 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs180954600 | chr6:46007271-46007272 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs567330747 | chr6:46007293-46007294 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs146070763 | chr6:46007306-46007307 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs547934387 | chr6:46007343-46007344 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs529616008 | chr6:46007354-46007355 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Leukemia | 21518781 | CNVD |
Cancer | 21637783 | CNVD |
Facial dysmorphism | 22105932 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Breast cancer | 21264507 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Cancer | 16751803 | CNVD |
Bladder cancer | 19088036 | CNVD |
Wilms tumour | 21544195 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Biliary cancer | 19435499 | CNVD |
Malaria | 21533027 | CNVD |
Retinoblastoma | 19183342 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Prostate cancer | 18632612 | CNVD |
Breast cancer | 21858162 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Autism | 21448237 | CNVD |
Melanoma | 18172304 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Autism | 22495311 | CNVD |
Cancer | 16790693 | CNVD |
Systemic lupus erythematosus | 17503323 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Urothelial carcinoma | 18382360 | CNVD |
Cancer | 21183584 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Gastric cancer | 17908304 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Neuroblastoma | 16790693 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Osteosarcoma | 16790693 | CNVD |
Biliary cancer | 20360734 | CNVD |
Breast cancer | 20360734 | CNVD |
Coronary artery disease | 20360734 | CNVD |
Crohn''s disease | 20360734 | CNVD |
Hypertension | 20360734 | CNVD |
Rheumatoid arthritis | 20360734 | CNVD |
Type 1 diabetes | 20360734 | CNVD |
Type 2 diabetes | 20360734 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Lung cancer | 18438408 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Osteosarcoma | 21197465 | CNVD |
Gastric cancer | 24379144 | CNVD |
Neuroblastoma | 18923191 | CNVD |
abnormal development | 18461090 | CNVD |
Breast cancer | 17603634 | CNVD |
Breast cancer | 21364760 | CNVD |
Colorectal cancer | 16790693 | CNVD |
Congenital adrenal hyperplasia | 18478071 | CNVD |
Congenital anomalies of the kidney and urinary tract | 18316590 | CNVD |
Systemic lupus erythematosus | 19287148 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Multiple myeloma | 16616336 | CNVD |
Chordoma | 18071362 | CNVD |
Follicular lymphoma | 16790693 | CNVD |
Osteosarcoma | 19286668 | CNVD |
Neurocytoma | 17123091 | CNVD |
Gastrointestinal stromal cancer | 20818650 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Heart disease | 21282601 | CNVD |
Acute lymphoblastic leukemia | 17443227 | CNVD |
Breast cancer | 16608533 | CNVD |
Breast cancer | 22522925 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr6:45998800-46012600 | Weak transcription | Fetal Intestine Small | intestine |
2 | chr6:46002600-46008000 | Weak transcription | Left Ventricle | heart |
3 | chr6:46002600-46011400 | Weak transcription | Right Ventricle | heart |
4 | chr6:46003400-46007600 | Weak transcription | HUVEC | blood vessel |
5 | chr6:46006000-46006200 | Active TSS | H1 Derived Mesenchymal Stem Cells | ES cell derived |
6 | chr6:46006000-46006200 | Enhancers | Lung | lung |
7 | chr6:46006000-46006200 | Enhancers | Psoas Muscle | Psoas |
8 | chr6:46006200-46006400 | Enhancers | HSMMtube | muscle |
9 | chr6:46006200-46016400 | Weak transcription | H1 Derived Mesenchymal Stem Cells | ES cell derived |
10 | chr6:46006400-46008000 | Weak transcription | Lung | lung |
11 | chr6:46007200-46011400 | Weak transcription | Fetal Intestine Large | intestine |
12 | chr6:46007600-46007800 | Enhancers | Adipose Nuclei | Adipose |
13 | chr6:46007600-46009400 | Enhancers | HUVEC | blood vessel |
14 | chr6:46007800-46010600 | Weak transcription | Adipose Nuclei | Adipose |
15 | chr6:46008000-46008400 | Enhancers | Left Ventricle | heart |
16 | chr6:46008000-46008400 | ZNF genes & repeats | Lung | lung |
17 | chr6:46008000-46008400 | Enhancers | Pancreas | Pancrea |
18 | chr6:46008400-46010200 | Weak transcription | Left Ventricle | heart |
19 | chr6:46008400-46010400 | Weak transcription | Lung | lung |
20 | chr6:46009400-46009800 | Weak transcription | HUVEC | blood vessel |
21 | chr6:46009800-46013800 | Enhancers | HUVEC | blood vessel |
22 | chr6:46010000-46010600 | Enhancers | Rectal Mucosa Donor 31 | rectum |
23 | chr6:46010200-46010400 | Enhancers | Placenta | Placenta |
24 | chr6:46010200-46013000 | Enhancers | Left Ventricle | heart |